Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Burrows, RF; Gan, ET; Gallus, AS; Wallace, EM; Burrows, EA
   A randomised double-blind placebo controlled trial of low molecular weightheparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study
   BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
   
   R.F. Burrows et al., "A randomised double-blind placebo controlled trial of low molecular weightheparin as prophylaxis in preventing venous thrombolic events after caesarean section: a pilot study", BR J OBST G, 108(8), 2001, pp. 835-839
2. Hakki, SI; Fareed, J; Hoppensteadt, DA; Abdullah, H; Camblin, J; Nasseri, AF; Hamadeh, O; Wright, T
   Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgery (vol 6, pg 206, 2000)
   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
   
   S.I. Hakki et al., "Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgery (vol 6, pg 206, 2000)", CL APPL T-H, 7(1), 2001, pp. 64-71
3. Billett, HH
   Direct and indirect antithrombins - Heparins, low molecular weight heparins, heparinoids, and hirudin
   CLINICS IN GERIATRIC MEDICINE
   
   H.H. Billett, "Direct and indirect antithrombins - Heparins, low molecular weight heparins, heparinoids, and hirudin", CLIN GERIAT, 17(1), 2001, pp. 15
4. Wellington, K; McClellan, K; Jarvis, B
   Reviparin - A review of its efficacy in the prevention and treatment of venous thromboembolism
   DRUGS
   
   K. Wellington et al., "Reviparin - A review of its efficacy in the prevention and treatment of venous thromboembolism", DRUGS, 61(8), 2001, pp. 1185-1209
5. Hakki, SI; Fareed, J; Hoppensteadt, DA; Abdullah, H; Camblin, J; Nasseri, AF; Hamadeh, O; Wright, T
   Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgery
   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
   
   S.I. Hakki et al., "Plasma tissue factor pathway inhibitor levels as a marker for postoperative bleeding after enoxaparin use in deep vein thrombosis prophylaxis in orthopedics and general surgery", CL APPL T-H, 6(4), 2000, pp. 206-212
6. Stern, SH; Wixson, RL; O'Connor, D
   Evaluation of the safety and efficacy of enoxaparin and warfarin for prevention of deep vein thrombosis after total knee arthroplasty
   JOURNAL OF ARTHROPLASTY
   
   S.H. Stern et al., "Evaluation of the safety and efficacy of enoxaparin and warfarin for prevention of deep vein thrombosis after total knee arthroplasty", J ARTHROPLA, 15(2), 2000, pp. 153-158
7. Lobato-Mendizabal, E; Majluf-Cruz, A
   Thrombophilia, thromboembolism and the use of the unfractionated and low-molecular-weight heparins
   REVISTA DE INVESTIGACION CLINICA
   
   E. Lobato-Mendizabal e A. Majluf-Cruz, "Thrombophilia, thromboembolism and the use of the unfractionated and low-molecular-weight heparins", REV INV CLI, 52(5), 2000, pp. 529-545
8. Klein, SM; Slaughter, TF; Vail, PT; Ginsberg, B; El-Moalem, HE; Alexander, R; D'Ercole, F; Greengrass, RA; Perumal, TTM; Welsby, I; Gan, TJ
   Thromboelastography as a perioperative measure of anticoagulation resulting from low molecular weight heparin: A comparison with anti-Xa concentrations
   ANESTHESIA AND ANALGESIA
   
   S.M. Klein et al., "Thromboelastography as a perioperative measure of anticoagulation resulting from low molecular weight heparin: A comparison with anti-Xa concentrations", ANESTH ANAL, 91(5), 2000, pp. 1091-1095
9. Nguyen, HN
   Effectiveness and safety of low-molecular-weight heparin for thrombosis prophylaxis
   DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
   
   H.N. Nguyen, "Effectiveness and safety of low-molecular-weight heparin for thrombosis prophylaxis", DEUT MED WO, 125(50), 2000, pp. 1550-1551
10. Ensom, MHH; Stephenson, MD
    Low-molecular-weight heparins in pregnancy
    PHARMACOTHERAPY
    
    M.H.H. Ensom e M.D. Stephenson, "Low-molecular-weight heparins in pregnancy", PHARMACOTHE, 19(9), 1999, pp. 1013-1025
11. Hovanessian, HC
    New-generation anticoagulants: The low molecular weight heparins
    ANNALS OF EMERGENCY MEDICINE
    
    H.C. Hovanessian, "New-generation anticoagulants: The low molecular weight heparins", ANN EMERG M, 34(6), 1999, pp. 768-779
12. Rydberg, EJ; Westfall, JM; Nicholas, RA
    Low-molecular-weight heparin in preventing and treating DVT
    AMERICAN FAMILY PHYSICIAN
    
    E.J. Rydberg et al., "Low-molecular-weight heparin in preventing and treating DVT", AM FAM PHYS, 59(6), 1999, pp. 1607-1612
13. SPINLER SA; NAWARSKAS JJ
    LOW-MOLECULAR-WEIGHT HEPARINS FOR ACUTE CORONARY SYNDROMES
    The Annals of pharmacotherapy
    
    S.A. Spinler e J.J. Nawarskas, "LOW-MOLECULAR-WEIGHT HEPARINS FOR ACUTE CORONARY SYNDROMES", The Annals of pharmacotherapy, 32(1), 1998, pp. 103-110
14. Huang, JN; Shimamura, A
    Low-molecular-weight heparins
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    
    J.N. Huang e A. Shimamura, "Low-molecular-weight heparins", HEMAT ONCOL, 12(6), 1998, pp. 1251
15. RODMAN DP
    LOW-MOLECULAR-WEIGHT HEPARINS IN CORONARY ARTERIAL THROMBUS DISEASE -A REVIEW OF THE LITERATURE
    Pharmacotherapy
    
    D.P. Rodman, "LOW-MOLECULAR-WEIGHT HEPARINS IN CORONARY ARTERIAL THROMBUS DISEASE -A REVIEW OF THE LITERATURE", Pharmacotherapy, 18(2), 1998, pp. 265-272
16. LECLERC JR
    LOW-MOLECULAR-WEIGHT HEPARIN-PROPHYLAXIS IN SURGICAL PATIENTS
    Clinical and applied thrombosis/hemostasis
    
    J.R. Leclerc, "LOW-MOLECULAR-WEIGHT HEPARIN-PROPHYLAXIS IN SURGICAL PATIENTS", Clinical and applied thrombosis/hemostasis, 3(3), 1997, pp. 153-156
17. KOROMPILIAS AV; CHEN LE; SEABER AV; URBANIAK JR
    ANTITHROMBOTIC POTENCIES OF ENOXAPARIN IN MICROVASCULAR SURGERY - INFLUENCE OF DOSE AND ADMINISTRATION METHODS ON PATENCY RATE OF CRUSHED ARTERIAL ANASTOMOSES
    The Journal of hand surgery
    
    A.V. Korompilias et al., "ANTITHROMBOTIC POTENCIES OF ENOXAPARIN IN MICROVASCULAR SURGERY - INFLUENCE OF DOSE AND ADMINISTRATION METHODS ON PATENCY RATE OF CRUSHED ARTERIAL ANASTOMOSES", The Journal of hand surgery, 22A(3), 1997, pp. 540-546
18. THOMAS DP
    DOES LOW-MOLECULAR-WEIGHT HEPARIN CAUSE LESS BLEEDING
    Thrombosis and haemostasis
    
    D.P. Thomas, "DOES LOW-MOLECULAR-WEIGHT HEPARIN CAUSE LESS BLEEDING", Thrombosis and haemostasis, 78(6), 1997, pp. 1422-1425
19. ANDERSEN BS
    POSTOPERATIVE ACTIVATION OF THE HEMOSTATIC SYSTEM - INFLUENCE OF PROLONGED THROMBOPROPHYLAXIS IN PATIENTS UNDERGOING TOTAL HIP-ARTHROPLASTY
    Haemostasis
    
    B.S. Andersen, "POSTOPERATIVE ACTIVATION OF THE HEMOSTATIC SYSTEM - INFLUENCE OF PROLONGED THROMBOPROPHYLAXIS IN PATIENTS UNDERGOING TOTAL HIP-ARTHROPLASTY", Haemostasis, 27(5), 1997, pp. 219-227
20. KALEBO P; ANTHMYR BA; ERIKSSON BI; ZACHRISSON BE
    OPTIMIZATION OF ASCENDING PHLEBOGRAPHY OF THE LEG FOR SCREENING OF DEEP-VEIN THROMBOSIS IN THROMBOPROPHYLACTIC TRIALS
    Acta radiologica
    
    P. Kalebo et al., "OPTIMIZATION OF ASCENDING PHLEBOGRAPHY OF THE LEG FOR SCREENING OF DEEP-VEIN THROMBOSIS IN THROMBOPROPHYLACTIC TRIALS", Acta radiologica, 38(2), 1997, pp. 320-326
21. PINEO GF; HULL RD
    LOW-MOLECULAR-WEIGHT HEPARIN - PROPHYLAXIS AND TREATMENT OF VENOUS THROMBOEMBOLISM
    Annual review of medicine
    
    G.F. Pineo e R.D. Hull, "LOW-MOLECULAR-WEIGHT HEPARIN - PROPHYLAXIS AND TREATMENT OF VENOUS THROMBOEMBOLISM", Annual review of medicine, 48, 1997, pp. 79-91
22. SCHMITZHUEBNER U
    PROPHYLAXIS WITH LOW-DOSE HEPARIN - SELEC TIVE OR GENERAL TREATMENT
    Der Internist
    
    U. Schmitzhuebner, "PROPHYLAXIS WITH LOW-DOSE HEPARIN - SELEC TIVE OR GENERAL TREATMENT", Der Internist, 38(7), 1997, pp. 667-671
23. KLEIN SM; DERCOLE F; GREENGRASS RA; WARNER DS
    ENOXAPARIN ASSOCIATED WITH PSOAS HEMATOMA AND LUMBAR PLEXOPATHY AFTERLUMBAR PLEXUS BLOCK
    Anesthesiology
    
    S.M. Klein et al., "ENOXAPARIN ASSOCIATED WITH PSOAS HEMATOMA AND LUMBAR PLEXOPATHY AFTERLUMBAR PLEXUS BLOCK", Anesthesiology, 87(6), 1997, pp. 1576-1579
24. NURMOHAMED MT; VANRIEL CMA; HENKENS CMA; KOOPMAN MMW; QUE GTH; DAZEMAR P; BULLER HR; TENCATE JW; HOEK JA; VANDERMEER J; VANDERHEUL C; TURPIE AGG; HALEY S; SICURELLA M
    LOW-MOLECULAR-WEIGHT HEPARIN AND COMPRESSION STOCKINGS IN THE PREVENTION OF VENOUS THROMBOEMBOLISM IN NEUROSURGERY
    Thrombosis and haemostasis
    
    M.T. Nurmohamed et al., "LOW-MOLECULAR-WEIGHT HEPARIN AND COMPRESSION STOCKINGS IN THE PREVENTION OF VENOUS THROMBOEMBOLISM IN NEUROSURGERY", Thrombosis and haemostasis, 75(2), 1996, pp. 233-238
25. VOGEL G; DEMPFLE CE; SPANNAGL M; LESKOPF W
    THE VALUE OF QUANTITATIVE FIBRIN MONOMER DETERMINATION IN THE EARLY DIAGNOSIS OF POSTOPERATIVE DEEP-VEIN THROMBOSIS
    Thrombosis research
    
    G. Vogel et al., "THE VALUE OF QUANTITATIVE FIBRIN MONOMER DETERMINATION IN THE EARLY DIAGNOSIS OF POSTOPERATIVE DEEP-VEIN THROMBOSIS", Thrombosis research, 81(2), 1996, pp. 241-251
26. GEERTS WH; JAY RM; CODE KI; CHEN EL; SZALAI JP; SAIBIL EA; HAMILTON PA
    A COMPARISON OF LOW-DOSE HEPARIN WITH LOW-MOLECULAR-WEIGHT HEPARIN ASPROPHYLAXIS AGAINST VENOUS THROMBOEMBOLISM AFTER MAJOR TRAUMA
    The New England journal of medicine
    
    W.H. Geerts et al., "A COMPARISON OF LOW-DOSE HEPARIN WITH LOW-MOLECULAR-WEIGHT HEPARIN ASPROPHYLAXIS AGAINST VENOUS THROMBOEMBOLISM AFTER MAJOR TRAUMA", The New England journal of medicine, 335(10), 1996, pp. 701-707
27. BERGQVIST D; LINDGREN B; MATZSCH T
    COMPARISON OF THE COST OF PREVENTING POSTOPERATIVE DEEP-VEIN THROMBOSIS WITH EITHER UNFRACTIONATED OR LOW-MOLECULAR-WEIGHT HEPARIN
    British Journal of Surgery
    
    D. Bergqvist et al., "COMPARISON OF THE COST OF PREVENTING POSTOPERATIVE DEEP-VEIN THROMBOSIS WITH EITHER UNFRACTIONATED OR LOW-MOLECULAR-WEIGHT HEPARIN", British Journal of Surgery, 83(11), 1996, pp. 1548-1552
28. LECLERC JR; GEERTS WH; DESJARDINS L; LAFLAMME GH; LESPERANCE B; DEMERS C; KASSIS J; CRUICKSHANK M; WHITMAN L; DELORME F
    PREVENTION OF VENOUS THROMBOEMBOLISM AFTER KNEE ARTHROPLASTY - A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING ENOXAPARIN WITH WARFARIN
    Annals of internal medicine
    
    J.R. Leclerc et al., "PREVENTION OF VENOUS THROMBOEMBOLISM AFTER KNEE ARTHROPLASTY - A RANDOMIZED, DOUBLE-BLIND TRIAL COMPARING ENOXAPARIN WITH WARFARIN", Annals of internal medicine, 124(7), 1996, pp. 619
29. HULL RD; RASKOB GE; PINEO GF; BRANT RF
    THE TREATMENT OF PROXIMAL VEIN-THROMBOSIS WITH SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN COMPARED WITH CONTINUOUS INTRAVENOUS HEPARIN
    Clinical and applied thrombosis/hemostasis
    
    R.D. Hull et al., "THE TREATMENT OF PROXIMAL VEIN-THROMBOSIS WITH SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN COMPARED WITH CONTINUOUS INTRAVENOUS HEPARIN", Clinical and applied thrombosis/hemostasis, 1(2), 1995, pp. 151-159
30. GONDRET R; DOMINICI L; ANGELARD B; DUBOS S; ALRAWI S; HUET Y; CLERGUE F; SAINTGUILY JL
    SAFETY OF PREOPERATIVE ENOXAPARIN IN HEAD AND NECK-CANCER SURGERY
    Head & neck
    
    R. Gondret et al., "SAFETY OF PREOPERATIVE ENOXAPARIN IN HEAD AND NECK-CANCER SURGERY", Head & neck, 17(1), 1995, pp. 1-6
31. TAPSON VF; HULL RD
    MANAGEMENT OF VENOUS THROMBOEMBOLIC DISEASE - THE IMPACT OF LOW-MOLECULAR-WEIGHT HEPARIN
    Clinics in chest medicine
    
    V.F. Tapson e R.D. Hull, "MANAGEMENT OF VENOUS THROMBOEMBOLIC DISEASE - THE IMPACT OF LOW-MOLECULAR-WEIGHT HEPARIN", Clinics in chest medicine, 16(2), 1995, pp. 281-294
32. WARKENTIN TE; LEVINE MN; HIRSH J; HORSEWOOD P; ROBERTS RS; GENT M; KELTON JG
    HEPARIN-INDUCED THROMBOCYTOPENIA IN PATIENTS TREATED WITH LOW-MOLECULAR-WEIGHT HEPARIN OR UNFRACTIONATED HEPARIN
    The New England journal of medicine
    
    T.E. Warkentin et al., "HEPARIN-INDUCED THROMBOCYTOPENIA IN PATIENTS TREATED WITH LOW-MOLECULAR-WEIGHT HEPARIN OR UNFRACTIONATED HEPARIN", The New England journal of medicine, 332(20), 1995, pp. 1330-1335
33. BERGQVIST D
    LOW-MOLECULAR-WEIGHT HEPARIN STARTED BEFORE SURGERY AS PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS - 2500 VERSUS 5000 XAI UNITS IN 2070 PATIENTS - REPLY
    British Journal of Surgery
    
    D. Bergqvist, "LOW-MOLECULAR-WEIGHT HEPARIN STARTED BEFORE SURGERY AS PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS - 2500 VERSUS 5000 XAI UNITS IN 2070 PATIENTS - REPLY", British Journal of Surgery, 82(9), 1995, pp. 1283-1284
34. KEARON C; HIRSH J
    STARTING PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM POSTOPERATIVELY
    Archives of internal medicine
    
    C. Kearon e J. Hirsh, "STARTING PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM POSTOPERATIVELY", Archives of internal medicine, 155(4), 1995, pp. 366-372
35. ONUNDARSON PT
    PREVENTION OF VENOUS THROMBOEMBOLISM IN SURGICAL PATIENTS
    Acta anaesthesiologica Scandinavica
    
    P.T. Onundarson, "PREVENTION OF VENOUS THROMBOEMBOLISM IN SURGICAL PATIENTS", Acta anaesthesiologica Scandinavica, 39, 1995, pp. 136-141
36. BARRELLIER MT; BOSSON JL; VIGNON C; ROUSSEAU JF; BESNARD M; BOISSEL M; FAUCHON G; PEGOIX M; THOMASSIN C; TRAHAY A; AUBRIOT JH; VIELPEAU C
    EARLY DETECTION OF POSTOPERATIVE DEEP-VEI N THROMBOSIS WITH DUPLEX SCANNING IN ORTHOPEDIC-SURGERY - A RETROSPECTIVE STUDY FROM 1,647 PATIENTS
    Journal des maladies vasculaires
    
    M.T. Barrellier et al., "EARLY DETECTION OF POSTOPERATIVE DEEP-VEI N THROMBOSIS WITH DUPLEX SCANNING IN ORTHOPEDIC-SURGERY - A RETROSPECTIVE STUDY FROM 1,647 PATIENTS", Journal des maladies vasculaires, 19(4), 1994, pp. 298-307
37. JONGBLOETS LMM; LENSING AWA; KOOPMAN MMW; BULLER HR; TENCATE JW
    LIMITATIONS OF COMPRESSION ULTRASOUND FOR THE DETECTION OF SYMPTOMLESS POSTOPERATIVE DEEP-VEIN THROMBOSIS
    Lancet
    
    L.M.M. Jongbloets et al., "LIMITATIONS OF COMPRESSION ULTRASOUND FOR THE DETECTION OF SYMPTOMLESS POSTOPERATIVE DEEP-VEIN THROMBOSIS", Lancet, 343(8906), 1994, pp. 1142-1144
38. HULL RD; PINEO GF
    THERAPEUTIC USE OF LOW-MOLECULAR-WEIGHT HEPARINS - KNOWLEDGE TO DATE AND THEIR APPLICATION TO THERAPY
    Seminars in thrombosis and hemostasis
    
    R.D. Hull e G.F. Pineo, "THERAPEUTIC USE OF LOW-MOLECULAR-WEIGHT HEPARINS - KNOWLEDGE TO DATE AND THEIR APPLICATION TO THERAPY", Seminars in thrombosis and hemostasis, 20(4), 1994, pp. 339-344
39. GREEN D; HIRSH J; HEIT J; PRINS M; DAVIDSON B; LENSING AWA
    LOW-MOLECULAR-WEIGHT HEPARIN - A CRITICAL ANALYSIS OF CLINICAL-TRIALS
    Pharmacological reviews
    
    D. Green et al., "LOW-MOLECULAR-WEIGHT HEPARIN - A CRITICAL ANALYSIS OF CLINICAL-TRIALS", Pharmacological reviews, 46(1), 1994, pp. 89-109
40. CARTER CA; SKOUTAKIS VA; SPIRO TE; WEST ME; TOOMS RE; JOE RH; KNUTSON TJ
    ENOXAPARIN - THE LOW-MOLECULAR-WEIGHT HEPARIN FOR PREVENTION OF POSTOPERATIVE THROMBOEMBOLIC COMPLICATIONS
    The Annals of pharmacotherapy
    
    C.A. Carter et al., "ENOXAPARIN - THE LOW-MOLECULAR-WEIGHT HEPARIN FOR PREVENTION OF POSTOPERATIVE THROMBOEMBOLIC COMPLICATIONS", The Annals of pharmacotherapy, 27(10), 1993, pp. 1223-1230
41. OFOSU FA
    PROPHYLACTIC DOSES OF ENOXAPARIN AND HEPARIN INHIBIT PROTHROMBIN ACTIVATION
    Seminars in thrombosis and hemostasis
    
    F.A. Ofosu, "PROPHYLACTIC DOSES OF ENOXAPARIN AND HEPARIN INHIBIT PROTHROMBIN ACTIVATION", Seminars in thrombosis and hemostasis, 19, 1993, pp. 29-30
42. HULL RD; PINEO GF
    THERAPEUTIC USE OF LOW-MOLECULAR-WEIGHT HEPARINS - THE KNOWLEDGE TO DATE AS APPLIED TO THERAPY
    Seminars in thrombosis and hemostasis
    
    R.D. Hull e G.F. Pineo, "THERAPEUTIC USE OF LOW-MOLECULAR-WEIGHT HEPARINS - THE KNOWLEDGE TO DATE AS APPLIED TO THERAPY", Seminars in thrombosis and hemostasis, 19, 1993, pp. 111-115